Bayesian Capital Management
Bayesian Capital Management reported 223 stocks worth $156M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are BABA (4.2%), NVDA (4.0%) and MSFT (3.9%). Compared with Q1 2026, the fund opened new positions in BABA, NVDA and QQQ, added to MSFT, ORCL and C, trimmed NKE, SNDK and NOW and sold out of XOM, META and RKLB.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  BABA Alibaba Group Hldg Ltd F | $6.5M | 4.2% | 68K | New position | 2 of 8 | |
| 2 |  NVDA Nvidia Corporation | $6.2M | 4.0% | 31K | New position | 3 of 8 | |
| 3 |  MSFT Microsoft Corp | $6M | 3.9% | 16K | +8,796 (+119%) | 4 of 8 | |
| 4 |  ORCL Oracle Corp | $5.1M | 3.3% | 35K | +32K (+1024%) | 5 of 8 | |
| 5 |  QQQ Invesco Qqq TR | $3.7M | 2.4% | 5,000 | New position | 3 of 8 | |
| 6 |  WFC Wells Fargo Co New | $3.1M | 2.0% | 38K | New position | 3 of 8 | |
| 7 |  ASML Asml Holding N V | $2.4M | 1.6% | 1,220 | New position | 1 of 8 | |
| 8 |  C Citigroup Inc | $2.2M | 1.4% | 16K | +6,891 (+78%) | 3 of 8 | |
| 9 |  PLTR Palantir Technologies Inc | $2.1M | 1.3% | 18K | New position | 4 of 8 | |
| 10 |  BSX Boston Scientific Corp | $2.1M | 1.3% | 49K | +25K (+106%) | 6 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
 XOM Exxon Mobil Corp | $2.9M | 17K |
 META Meta Platforms Inc | $2.7M | 4,700 |
 RKLB Rocket Lab Corp | $2.6M | 41K |
 XBI Spdr Series Trust | $2.5M | 20K |
 CRWV Coreweave Inc | $2.4M | 31K |
🔒 Free account: see all 30.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 14, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Bayesian Capital Management 13F FAQ
What does Bayesian Capital Management own?
Bayesian Capital Management reported 223 stocks worth $156M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are BABA (4.2%), NVDA (4.0%) and MSFT (3.9%). The table above lists every position in the filing (the top 10 without an account).
What did Bayesian Capital Management buy and sell in Q2 2026?
Compared with Q1 2026: 191 new positions, 20 added to, 12 trimmed and 105 sold out. New positions include BABA, NVDA and QQQ. It sold all of XOM, META and RKLB.
When will Bayesian Capital Management file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Bayesian Capital Management's portfolio worth?
The Q2 2026 filing reports $156M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.